ACC Annual Scientific Session In Brief

COMPASS-HF: Remote monitoring with Medtronic's investigational Chronicle implantable hemodynamic monitor (IHM) is associated with 41% fewer heart-failure related hospitalizations compared with optimal medical management alone in the 274-patient, 28-center randomized COMPASS-HF (Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure) study. Enrollees had NYHA Class III or IV heart failure and made at least one heart failure-related hospital trip in the last six months. Robert Bourge, MD, University of Alabama-Birmingham, presented the study results at the American College of Cardiology Annual Scientific Session in Orlando March 8...